In pancreatic cancer, PHGDH expression is significantly upregulated and correlates strongly with tumor size, lymph node metastasis, and clinical stage; furthermore, it serves as an independent prognostic biomarker in affected patients (88, 89). This evidence concerns the gene PHGDH and pancreatic neoplasm.